1-11 of 11
Tibor Keler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In Situ Vaccination Improves Efficacy of PD-1 Blockade in Unresponsive Lymphoma Tumors through Induction of a Highly Efficient Cross-Presenting Dendritic Cell Subset Expressing TLR3

Linda Hammerich, Maxime Dhainaut, Tibor Keler, Thomas Davis, MD, Andres M Salazar, Brian D Brown, Joshua Brody, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4106.
https://doi.org/10.1182/blood.V130.Suppl_1.4106.4106
Published: 2017
Journal Articles

Anti-CD27 Enhances Lymphoma Immunotherapy through Profound Myeloid Cell Recruitment

Anna H Turaj, MSc, Vikki L Field, Claude H.T. Chan, PhD, Christine A. Penfold, BSc, Jinny H. Kim, PhD, Sonya James, PhD, Kerry L Cox, Tibor Keler, PhD, Peter M Johnson, MA, MD, Aymen Al-Shamkhani, PhD, Stephen A Beers, PhD, Martin J. Glennie, PhD, Mark S Cragg, PhD, Sean H Lim, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3024.
https://doi.org/10.1182/blood.V128.22.3024.3024
Published: 2016
Journal Articles

CDX-1140, a Novel Agonist CD40 Antibody with Potent Anti-Lymphoma Activity

Li-Zhen He, MD, James Testa, PhD, Wasiuk Anna, PhD, Weidlick Jeffery, Crystal Sisson, Laura A. Vitale, Thomas O'Neill, Andrea Crocker, Jenifer Widger, Joel Goldstein, PhD, Henry C. Marsh Jr., PhD, Tibor Keler, PhD
Journal: Blood
Blood (2016) 128 (22): 1848.
https://doi.org/10.1182/blood.V128.22.1848.1848
Published: 2016
Journal Articles

Combining In Situ Vaccination with Immune Checkpoint Blockade Induces Long-Term Regression of Lymphoma Tumors

Linda Hammerich, PhD, Thomas A. Davis, MD, Tibor Keler, PhD, Andres M Salazar, Joshua Brody, MD
Journal: Blood
Blood (2016) 128 (22): 465.
https://doi.org/10.1182/blood.V128.22.465.465
Published: 2016
Journal Articles

Turning a Tumor into a Vaccine Factory: In Situ Vaccination for Low-Grade Lymphoma

Thomas Marron, MD PhD, Nina Bhardwaj, MD PhD, Elizabeth Crowley, Tibor Keler, PhD, Thomas A. Davis, MD, Joshua Brody, MD
Journal: Blood
Blood (2014) 124 (21): 5473.
https://doi.org/10.1182/blood.V124.21.5473.5473
Published: 2014
Journal Articles

A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers

Niroshana Anandasabapathy, MD, PhD, Arlene Hurley, ANP, CCRC, Marina Caskey, Christine Trumpfheller, Popi Sarma, James Pring, Maggie Pack, Renee Riggs, Jennifer Green, Michael Yellin, MD, Thomas A. Davis, MD, Tibor Keler, PhD, Sarah Schlesinger, MD
Journal: Blood
Blood (2012) 120 (21): 4124.
https://doi.org/10.1182/blood.V120.21.4124.4124
Published: 2012
Journal Articles

Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells

Bithi Chatterjee, Anna Smed-Sörensen, Lillian Cohn, Cécile Chalouni, Richard Vandlen, Byoung-Chul Lee, Jenifer Widger, Tibor Keler, Lélia Delamarre, Ira Mellman
Journal: Blood
Blood (2012) 120 (10): 2011–2020.
https://doi.org/10.1182/blood-2012-01-402370
Published: 2012
Includes: Supplemental data
Journal Articles

Development of a Human Anti-CD27 Antibody with Efficacy in Lymphoma and Leukemia Models by Two Distinct Mechanisms

Li-Zhen He, MD, Larry Thomas, PhD, Jeffery Weidlick, Laura Vitale, Tom O'Neill, Naseem Prostak, Karuna Sundarapandiyan, Henry Marsh, PhD, Michael Yellin, MD, Thomas A. Davis, MD, Tibor Keler, PhD
Journal: Blood
Blood (2011) 118 (21): 2861.
https://doi.org/10.1182/blood.V118.21.2861.2861
Published: 2011
Journal Articles

Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody

Cheolho Cheong, Jae-Hoon Choi, Laura Vitale, Li-Zhen He, Christine Trumpfheller, Leonia Bozzacco, Yoonkyung Do, Godwin Nchinda, Sung Ho Park, Durga Bhavani Dandamudi, Elina Shrestha, Maggi Pack, Han-Woong Lee, Tibor Keler, Ralph M. Steinman, Chae Gyu Park
Journal: Blood
Blood (2010) 116 (19): 3828–3838.
https://doi.org/10.1182/blood-2010-06-288068
Published: 2010
Journal Articles

The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma

Peter Borchmann, John F. Treml, Hinrich Hansen, Claudia Gottstein, Roland Schnell, Oliver Staak, Hui-fen Zhang, Thomas Davis, Tibor Keler, Volker Diehl, Robert F. Graziano, Andreas Engert
Journal: Blood
Blood (2003) 102 (10): 3737–3742.
https://doi.org/10.1182/blood-2003-02-0515
Published: 2003
Journal Articles

The FcγRIa (CD64) Ligand Binding Chain Triggers Major Histocompatibility Complex Class II Antigen Presentation Independently of Its Associated FcR γ-Chain

Martine J. van Vugt, Monique J. Kleijmeer, Tibor Keler, Ingrid Zeelenberg, Marc A. van Dijk, Jeanette H.W. Leusen, Hans J. Geuze, Jan G.J. van de Winkel
Journal: Blood
Blood (1999) 94 (2): 808–817.
https://doi.org/10.1182/blood.V94.2.808
Published: 1999